Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_assertion type Assertion NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_head.
- NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_assertion description "[To better understand factors regulating TPO levels, we measured blood levels of TPO in patients with impaired platelet production due to aplastic anemia (AA) and with platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusion purpura (PTP), drug purpura (DP), and X-linked thrombocytopenia (XLTP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_provenance.
- NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_assertion evidence source_evidence_literature NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_provenance.
- NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_assertion SIO_000772 8639762 NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_provenance.
- NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_assertion wasDerivedFrom befree-20140225 NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_provenance.
- NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_assertion wasGeneratedBy ECO_0000203 NP556038.RAIHTiXC-z1aU7S7PmDnPRVVgmBdiX2GmfLtyM80gl3_0130_provenance.